Adjuvant Axitinib Therapy of Renal Cell Cancer in High Risk Patients
Clinical trial NCT01599754 · TERMINATED
Trial details
- NCT number
- NCT01599754
- Sponsor
- SFJ Pharma Ltd. II
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2017-10-10
- Enrollment
- 724
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.